NIH neuroscientist loses second paper, again the result of first author misconduct

Stanley Rapoport. Source: NIH
Stanley Rapoport. Source: NIH

Stanley Rapoport, a neuroscientist in the National Institute on Aging, isn’t having a lot of luck with his first authors. One committed misconduct and cost him a paper in the journal Age last year, and now he’s lost another paper with a different first author, but for the exact same reason.

The latest paper, in Neurochemical Research, examined whether chronic doses of aspirin reduce brain inflammation. It has been cited 14 times, according to Thomson Scientific’s Web of Knowledge.

Here’s more from the note: Continue reading NIH neuroscientist loses second paper, again the result of first author misconduct

Misconduct earns researcher a five-year ban on federal funding

ori logoA University of Minnesota former chemistry graduate student has been banned from receiving federal funding for five years based on “a preponderance of the evidence that the Respondent intentionally and knowingly engaged in research misconduct.”

Venkata J. Reddy appears to have manipulated findings in one R01 grant application. In recent years, bans are less common than having research supervised. What’s also unusual is that the sanction appeared to have begun two years ago, in 2013, because it lifts August 26, 2018. The report, which is scheduled to published tomorrow in the Federal Register, says the debarment has a “joint jurisdiction,” suggesting another agency may be involved. [See first update at end of post.]

According to the ORI notice, Reddy “intentionally and knowingly engaged in research misconduct by falsifying and/or fabricating data that was provided to his mentor” for an R01 application to the National Institute of General Medical Sciences (NIGMS). More specifically: Continue reading Misconduct earns researcher a five-year ban on federal funding

Drug study pulled after researchers admit altering trial protocol

egypt anaesthesiaThe Egyptian Journal of Anaesthesia is retracting a 2014 paper by a pair of researchers at Cairo University who appear to have tinkered with their protocol after having received ethics approval.

The paper, titled “Can Sugammadex improve the reversal profile of Atracurium under Sevoflurane anesthesia?” was written by Heba Ismail Ahmed Nagy and Hany Wafik Elkadi, both in the department of anesthesiology.

Sugammadex, or Bridion, is given to rapidly reverse the effects of drugs that keep patients motionless during surgery. It is available throughout the world but not, as it happens, in the United States, where the Food and Drug Administration has refused to approve the agent because of fears that it might provoke severe allergic-like reactions.

According to the retraction notice:

Continue reading Drug study pulled after researchers admit altering trial protocol

It’s a man’s world — for one peer reviewer, at least

We’ve written quite a lot about the perks and pitfalls of the peer review system, but one thing we never really touched on was the risk that a reviewer might be … well, not to put too fine a point on it: a dope.

But Fiona Ingleby can speak to that. Ingleby, a postdoc in evolutionary genetics at the University of Sussex in the United Kingdom, co-wrote an article on gender differences in the transition from PhD-dom to postdoc land and submitted it to a journal for consideration. What she heard back was lamentably ironic — and grossly sexist. Continue reading It’s a man’s world — for one peer reviewer, at least

Chem paper fails to catalyze when wrong files are “inadvertently used”

joceah_v080i008.inddThree chemists at the Indian Institute of Technology Guwahati in India have retracted a paper from the Journal of Organic Chemistry because the “incorrect files were inadvertently used.”

The article, “Room-Temperature Cu(II)-Catalyzed Chemo- and Regioselective Ortho-Nitration of Arenes via C–H Functionalization,” described a protocol to perform nitration — the addition of nitro groups onto an organic compound — using an inexpensive copper catalyst.

All three authors signed the one-sentence notice:

Continue reading Chem paper fails to catalyze when wrong files are “inadvertently used”

Reporting errors sink chem paper on liquid-liquid equilibrium

Jced_coverA team of chemists at Hunan University and Zhejiang Shuyang Chemical Company in China have retracted a paper from the Journal of Chemical & Engineering Data after “inconsistencies with the literature” led them to discover “errors” in the way the data were reported.

According to the corresponding author Qinbo Wang, in December 2014, Robert Chirico, an associate editor at the journal, contacted Wang with concerns that the paper’s data were an anomaly.

Wang then went through the original notes with the first author, and realized that the data reported in the paper didn’t match the experimental results. The lab then conducted further experiments, and discovered that multiple corrections would be necessary. They were, as Wang told us: Continue reading Reporting errors sink chem paper on liquid-liquid equilibrium

Snail egg article retracted for fishing for material from six other papers

APJTB_ak1The first author of a review article on extracting pharmacological compounds from marine organisms, published in the Asian Pacific Journal of Tropical Biomedicine, has retracted it due to plagiarism.

There were also some authorship issues, according to the retraction notice for the paper, which absolves the last author, based at Pondicherry University in India, from responsibility:

This article has been retracted at the request of the Editor-in-Chief and the First Author. Both the first author and the journal’s editor confirmed that Dr. A Yogamoorthi is not responsible for the plagiarism since his/her name was added without consent.

There is one other author, R. Siva Sankar, also based at Pondicherry. Somewhere along the way, according to the retraction note, the paper scooped up wording from six papers previously published by researchers in Australia. Here’s more from the retraction note for “Antimicrobial secondary metabolites from marine gastropod egg capsules and egg masses”: Continue reading Snail egg article retracted for fishing for material from six other papers

Chinese medical case study erased after guardian consent withdrawn

JMCRThe editor of the Journal of Medical Case Reports, a BioMed Central title, has retracted and removed a case study of a novel surgical treatment after the patient’s legal guardian withdrew consent post-publication.

The paper, “Novel two-stage surgical treatment for Cantrell syndrome complicated by severe pulmonary hypertension: a case report,” describes the treatment of a six-month-old Han Chinese girl suffering from a rare combination of birth defects called Cantrell syndrome, complicated by pulmonary hypertension.

The original article, published in March 2014, has been removed from the journal’s website, though the abstract can be read on PubMed. It is unclear whether the authors, the child’s guardian, or some other party informed the editor of the withdrawal of consent.

The brief notice offers few details:

Continue reading Chinese medical case study erased after guardian consent withdrawn

Former Florida ob-gyn prof notches eighth retraction

University of Florida
University of Florida

Nasser Chegini, the former University of Florida professor currently under investigation by the Office of Research Integrity (ORI), has now had eight papers retracted.

The eighth paper, in the journal Reproductive Biology and Endocrinology, is about the effect of a compound used during fertility treatments on Smads, signaling molecules that carry messages from TGF-beta receptors to the nucleus. It’s being retracted disappeared due to the discovery of data that “have been fabricated or falsified by the last author” — namely, Chegini.

Here’s more from the notice for “Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells:” Continue reading Former Florida ob-gyn prof notches eighth retraction

Retraction Watch is hiring!

anniversarySince becoming our intern in June of last year, and then our first-ever staff writer in October, Cat Ferguson has written more than 200 posts, breaking news left and right. But as we noted on Twitter the other day with not a small degree of sadness, Cat has left Retraction Watch for a great gig at BuzzFeed.

That means we’re hiring.

The job is definitely fast-paced. Continue reading Retraction Watch is hiring!